Turn ASH data into business-critical insights. 30 high-prescribing hem/oncs analyze 10 Non-Hodgkin Lymphoma abstracts to help you prepare for what’s next. Take the guesswork out of understanding changes in prescribing behavior. Get your 65+ slide report.

Non-Hodgkin Lymphoma Report ASH 2021

American Society of Hematology

Atlanta, GA
Dec 11 to Dec 14

Share: